FIELD: chemistry; medicine.
SUBSTANCE: invention concerns carboxylic acid compounds of the formula (I) , where R1 is hydrogen or C1-4alkyl; m is 2 or 3; n is 0-2; R2 is phenyl, naphtyl, benzofuran, benzothiophene; Q is -CH2-O-Cyc1, -CH2-Cyc2, -L-Cyc3, each of R3a and R3b radicals is independently a hydrogen, alkyl, or the R3a and R3b radicals together form tetrahydro-2H-pyran; pharmaceutically acceptable salts, method of obtaining them, and pharmaceutical agent including this compound as active component. Compound of the formula (I) displays antagonistic effect on PGE2 receptor, especially EP3 receptor, which is its subtype, and is applied in prevention and/or treatment of itching, pain, urination disorder or diseases caused by stress.
EFFECT: increased efficiency of compounds.
11 cl, 37 ex, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF CARBOXYLIC ACIDS AND PHARMACEUTICAL AGENT COMPRISING THEIR AS ACTIVE COMPONENT | 2002 |
|
RU2315746C2 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
AVB6 INTEGRIN INHIBITORS | 2018 |
|
RU2769702C2 |
PHENYL DERIVATIVES | 2012 |
|
RU2619105C2 |
DERIVATIVE OF CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION AND MEDICINE OF PREVENTING AND/OR CURING DISEASES, CAUSED BY ACTIVATION OF DP RECEPTOR, USE OF SUCH DERIVATIVE FOR MAKING SUCH MEDICINE, METHOD OF PREVENTING AND/OR CURING DISEASES, CAUSED BY ACTIVATION OF DP RECEPTORS | 2003 |
|
RU2329256C2 |
N-PHENYLARYLSULFONYLAMIDE, PHARMACEUTICAL COMPOSITION CONTAINING INDICATED SUBSTANCE AS ACTIVE COMPONENT, COMPOUND AS INTERMEDIATE IN SYNTHESIS OF INDICATED COMPOUND AND METHOD FOR ITS PREPARING | 2002 |
|
RU2299202C2 |
IMIDAZOTRIAZINONE COMPOUNDS | 2011 |
|
RU2603140C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
NEW HYDROXAMIC ACID DERIVATIVE | 2011 |
|
RU2575129C2 |
8-AZAPROSTAGLANDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND AGENT FOR PROPHYLAXIS OF DISEASES | 2003 |
|
RU2306309C2 |
Authors
Dates
2008-10-10—Published
2004-02-06—Filed